Specialty
Article
Uncovering behind-the-scenes challenges in bringing gene therapies to market
June 07, 2022
Patients getting access to expensive gene therapies is just one of the many challenges to bringing these sometimes life-saving drugs to market.
Video
What Is Drug Trend and How to Manage it
April 21, 2022
Drug trend, a good annual barometer for plan sponsor who are looking to control traditional and specialty drug costs, can and should be managed to improve medication access.
This topic was the foc...
Article
Three specialty drug trends to prepare for: Biosimilars, gene and cell therapies, cancer drugs
April 20, 2022
Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed.
This topic was the focus of a breakout...
Article
Improving Specialty Prescribing Turnaround Time
March 10, 2022
Through secure automation, Accredo is improving the specialty prescribing journey for physicians so patients receive their medication faster.
Article
How to have a data-driven discussion on gene and cellular therapies
As the number of approved gene and cellular therapies grows, you can start preparing your organization now by taking the right next steps.
Read More
Article
Game changer: Three things to know about interchangeable biosimilars
The first interchangeable biosimilar is now available. Here’s what plans need to know about these products, which – like generics – can be substituted at the pharmacy.
Read More